SCHEMBL4024828

SCHEMBL4024828

O=C(NC1CCN(c2ncnc3c(F)cc(F)cc23)CC1)c1cccc(Cl)c1Cl.O=C(NC1CCN(c2ncnc3cc(C(F)(F)F)cc(C(F)(F)F)c23)CC1)c1cccc(Cl)c1Cl

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PAK1 Q13153 7/20 0.51
CNR1 P21554 3/20 0.42
MAP3K5 Q99683 3/20 0.41
CNR2 P34972 2/20 0.41
RPS6KB1 P23443 1/20 0.40
HPGD P15428 2/20 0.39
ALDH1A1 P00352 1/20 0.39
MAPT P10636 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
KIT P10721 1/20 0.39
P2RX7 Q99572 1/20 0.38
PAK3 O75914 1/20 0.37
PAK2 Q13177 1/20 0.37
KMT2A Q03164 2/20 0.37
MEN1 O00255 1/20 0.37
CYP3A4 P08684 1/20 0.37
MAP3K6 O95382 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4024033 0.91 PAK1 (0.56) PAK1CNR1MAP3K5CNR2RPS6KB1
SCHEMBL4582674 0.87 PAK1 (0.65) PAK1CNR1MAP3K5CNR2HPGD
SCHEMBL4023993 0.82 PAK1 (0.46) PAK1CNR1MAP3K5CNR2P2RX7
SCHEMBL4581785 0.81 PAK1 (0.63) PAK1CNR1CNR2KITP2RX7
SCHEMBL4024014 0.81 PAK1 (0.52) PAK1CNR1MAP3K5CNR2
SCHEMBL4022833 0.80 PAK1 (0.57) PAK1CNR1CNR2RPS6KB1KIT
SCHEMBL4021914 0.80 PAK1 (0.63) PAK1CNR1HPGDKITP2RX7
SCHEMBL4581607 0.80 PAK1 (0.65) PAK1CNR1MAP3K5CNR2HPGD
SCHEMBL4023766 0.79 PAK1 (0.66) PAK1CNR1MAP3K5CNR2HPGD
SCHEMBL4016188 0.79 PAK1 (0.59) PAK1CNR1CNR2KITP2RX7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2066654-A1 N-(1-HETARYLPIPERIDIN-4-YL)(HET)ARYLAMIDES AS EP2 RECEPTOR MODULATORS Bayer Schering Pharma AG (DE) 2009-06-10 EP claimed
WO-2008028691-A1 N-(1-HETARYLPIPERIDIN-4-YL)(HET)ARYLAMIDES AS EP2 RECEPTOR MODULATORS BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2008-03-13 WO claimed